|
DREAMM-5 platform trial: Belantamab mafodotin in combination with novel agents in patients with relapsed/refractory multiple myeloma (RRMM). |
|
|
Consulting or Advisory Role - Celgene; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Oncopeptides; Sanofi; Takeda |
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Oncopeptides (Inst); Takeda (Inst) |
|
|
No Relationships to Disclose |
|
|
Employment - GlaxoSmithKline |
Stock and Other Ownership Interests - GlaxoSmithKline |
|
|
Employment - GlaxoSmithKline |
|
|
Employment - GlaxoSmithKline |
Stock and Other Ownership Interests - GlaxoSmithKline; Novartis |
Travel, Accommodations, Expenses - GlaxoSmithKline |
|
|
Employment - GlaxoSmithKline |
Stock and Other Ownership Interests - GlaxoSmithKline |
|
|
Employment - GlaxoSmithKline |
Stock and Other Ownership Interests - GlaxoSmithKline; GlaxoSmithKline |
Travel, Accommodations, Expenses - GlaxoSmithKline |
|
|
Employment - GlaxoSmithKline |
Stock and Other Ownership Interests - GlaxoSmithKline |
|
|
Employment - GlaxoSmithKline |
Stock and Other Ownership Interests - GlaxoSmithKline |
|
|
Employment - GlaxoSmithKline |
Stock and Other Ownership Interests - GlaxoSmithKline |
|
Christoph Matthias Ahlers |
Employment - GlaxoSmithKline |
Stock and Other Ownership Interests - GlaxoSmithKline |
Travel, Accommodations, Expenses - GlaxoSmithKline |
|
|
Employment - GlaxoSmithKline |
Leadership - GlaxoSmithKline |
Stock and Other Ownership Interests - Bristol-Myers Squibb; GlaxoSmithKline |
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline |
Research Funding - GlaxoSmithKline |
Patents, Royalties, Other Intellectual Property - AstraZeneca; GlaxoSmithKline |
Travel, Accommodations, Expenses - GlaxoSmithKline |
|
|
Employment - GlaxoSmithKline |
Stock and Other Ownership Interests - GlaxoSmithKline |
Travel, Accommodations, Expenses - GlaxoSmithKline |
|
|
Employment - GlaxoSmithKline |
Stock and Other Ownership Interests - GlaxoSmithKline |
|
|
Employment - GlaxoSmithKline |
Stock and Other Ownership Interests - GlaxoSmithKline |
Patents, Royalties, Other Intellectual Property - GlaxoSmithKline |
|
|
No Relationships to Disclose |